These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 25127374)

  • 1. Nuclear mobility and activity of FOXA1 with androgen receptor are regulated by SUMOylation.
    Sutinen P; Rahkama V; Rytinki M; Palvimo JJ
    Mol Endocrinol; 2014 Oct; 28(10):1719-28. PubMed ID: 25127374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SUMO-specific protease 1 (SENP1) reverses the hormone-augmented SUMOylation of androgen receptor and modulates gene responses in prostate cancer cells.
    Kaikkonen S; Jääskeläinen T; Karvonen U; Rytinki MM; Makkonen H; Gioeli D; Paschal BM; Palvimo JJ
    Mol Endocrinol; 2009 Mar; 23(3):292-307. PubMed ID: 19116244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NFI transcription factors interact with FOXA1 to regulate prostate-specific gene expression.
    Grabowska MM; Elliott AD; DeGraff DJ; Anderson PD; Anumanthan G; Yamashita H; Sun Q; Friedman DB; Hachey DL; Yu X; Sheehan JH; Ahn JM; Raj GV; Piston DW; Gronostajski RM; Matusik RJ
    Mol Endocrinol; 2014 Jun; 28(6):949-64. PubMed ID: 24801505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SUMO ligase PIAS1 functions as a target gene selective androgen receptor coregulator on prostate cancer cell chromatin.
    Toropainen S; Malinen M; Kaikkonen S; Rytinki M; Jääskeläinen T; Sahu B; Jänne OA; Palvimo JJ
    Nucleic Acids Res; 2015 Jan; 43(2):848-61. PubMed ID: 25552417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic SUMOylation is linked to the activity cycles of androgen receptor in the cell nucleus.
    Rytinki M; Kaikkonen S; Sutinen P; Paakinaho V; Rahkama V; Palvimo JJ
    Mol Cell Biol; 2012 Oct; 32(20):4195-205. PubMed ID: 22890844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FOXA1 modulates EAF2 regulation of AR transcriptional activity, cell proliferation, and migration in prostate cancer cells.
    Guo W; Keener AL; Jing Y; Cai L; Ai J; Zhang J; Fisher AL; Fu G; Wang Z
    Prostate; 2015 Jun; 75(9):976-87. PubMed ID: 25808853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of androgen receptor SUMOylation.
    Rytinki MM; Kaikkonen S; Sutinen P; Palvimo JJ
    Methods Mol Biol; 2011; 776():183-97. PubMed ID: 21796528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Foxa1 and Foxa2 interact with the androgen receptor to regulate prostate and epididymal genes differentially.
    Yu X; Gupta A; Wang Y; Suzuki K; Mirosevich J; Orgebin-Crist MC; Matusik RJ
    Ann N Y Acad Sci; 2005 Dec; 1061():77-93. PubMed ID: 16467259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostaglandin 15d-PGJ(2) inhibits androgen receptor signaling in prostate cancer cells.
    Kaikkonen S; Paakinaho V; Sutinen P; Levonen AL; Palvimo JJ
    Mol Endocrinol; 2013 Feb; 27(2):212-23. PubMed ID: 23192983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SUMOylation modulates the transcriptional activity of androgen receptor in a target gene and pathway selective manner.
    Sutinen P; Malinen M; Heikkinen S; Palvimo JJ
    Nucleic Acids Res; 2014 Jul; 42(13):8310-9. PubMed ID: 24981513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upstream stimulatory factor 2, a novel FoxA1-interacting protein, is involved in prostate-specific gene expression.
    Sun Q; Yu X; Degraff DJ; Matusik RJ
    Mol Endocrinol; 2009 Dec; 23(12):2038-47. PubMed ID: 19846536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cooperativity and equilibrium with FOXA1 define the androgen receptor transcriptional program.
    Jin HJ; Zhao JC; Wu L; Kim J; Yu J
    Nat Commun; 2014 May; 5():3972. PubMed ID: 24875621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SUMOylation of ATF3 alters its transcriptional activity on regulation of TP53 gene.
    Wang CM; Brennan VC; Gutierrez NM; Wang X; Wang L; Yang WH
    J Cell Biochem; 2013 Mar; 114(3):589-98. PubMed ID: 22991139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central role of SUMOylation in the regulation of chromatin interactions and transcriptional outputs of the androgen receptor in prostate cancer cells.
    Launonen KM; Varis V; Aaltonen N; Niskanen EA; Varjosalo M; Paakinaho V; Palvimo JJ
    Nucleic Acids Res; 2024 Sep; 52(16):9519-9535. PubMed ID: 39106160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SUMO-3 enhances androgen receptor transcriptional activity through a sumoylation-independent mechanism in prostate cancer cells.
    Zheng Z; Cai C; Omwancha J; Chen SY; Baslan T; Shemshedini L
    J Biol Chem; 2006 Feb; 281(7):4002-12. PubMed ID: 16361251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pioneer of prostate cancer: past, present and the future of FOXA1.
    Teng M; Zhou S; Cai C; Lupien M; He HH
    Protein Cell; 2021 Jan; 12(1):29-38. PubMed ID: 32946061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated levels of FOXA1 facilitate androgen receptor chromatin binding resulting in a CRPC-like phenotype.
    Robinson JL; Hickey TE; Warren AY; Vowler SL; Carroll T; Lamb AD; Papoutsoglou N; Neal DE; Tilley WD; Carroll JS
    Oncogene; 2014 Dec; 33(50):5666-74. PubMed ID: 24292680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual role of FoxA1 in androgen receptor binding to chromatin, androgen signalling and prostate cancer.
    Sahu B; Laakso M; Ovaska K; Mirtti T; Lundin J; Rannikko A; Sankila A; Turunen JP; Lundin M; Konsti J; Vesterinen T; Nordling S; Kallioniemi O; Hautaniemi S; Jänne OA
    EMBO J; 2011 Sep; 30(19):3962-76. PubMed ID: 21915096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SUMO3 modification by PIAS1 modulates androgen receptor cellular distribution and stability.
    Yang N; Liu S; Qin T; Liu X; Watanabe N; Mayo KH; Li J; Li X
    Cell Commun Signal; 2019 Nov; 17(1):153. PubMed ID: 31752909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FOXA1: a transcription factor with parallel functions in development and cancer.
    Bernardo GM; Keri RA
    Biosci Rep; 2012 Apr; 32(2):113-30. PubMed ID: 22115363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.